Pharmacoeconomic Evaluation on the Literature of Aripiprazol vs.Risperidone in the Treatment of Schizophrenia

Pharmacoeconomic Evaluation on the Literature of Aripiprazol vs.Risperidone in the Treatment of Schizophrenia / 中国药房

Jianqing TAO; Jiabin LIU; Xuebing YIN; Xiafang WU.

China Pharmacy ; (12)2007.

Article in Chinese | WPRIM | ID: wpr-529528

ABSTRACT

0.05).

CONCLUSION:

There is no pharmacoeconomic difference between aripiprazol and risperidone in the treatment schizophrenia.

Aripiprazole; Risperidone; Schizophrenia; Meta-analysis; Cost minimization analysis

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: China Pharmacy Year: 2007 Type: Article

MEDLINE

LILACS

LIS

Fulltext

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: China Pharmacy Year: 2007 Type: Article